| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now | 1 | Zacks | ||
| 12.05. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 08.05. | LifeStance Health Group prices secondary offering at $8.15 per share | 1 | Seeking Alpha | ||
| 08.05. | LifeStance Health prices secondary offering at $8.15 per share | 1 | Investing.com | ||
| 08.05. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 07.05. | LifeStance: Aktionäre wollen 35 Millionen Aktien platzieren | 1 | Investing.com Deutsch | ||
| 07.05. | LifeStance stockholders plan 35M share offering | 1 | Investing.com | ||
| 07.05. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Launch of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 07.05. | Lifestance forecasts $1.64B-$1.68B 2026 revenue while targeting mid-teens adjusted EBITDA margins by 2028 | 2 | Seeking Alpha | ||
| 07.05. | LifeStance hebt nach starkem ersten Viertel die Prognose an: Umsatz wächst um 21 % | - | Investing.com Deutsch | ||
| 07.05. | LifeStance Q1 2026 presentation: 21% revenue growth, guidance raised | 1 | Investing.com | ||
| 07.05. | LifeStance Health Group, Inc. Q1 Earnings Summary | 1 | RTTNews | ||
| 07.05. | LifeStance Health Group GAAP EPS of $0.04 beats by $0.03, revenue of $403.5M beats by $17.38M | 1 | Seeking Alpha | ||
| 07.05. | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | 334 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| 28.04. | LifeStance Health: Aktie legt nach Ankündigung der Aufnahme in den S&P SmallCap 600 deutlich zu | 2 | Investing.com Deutsch | ||
| 28.04. | S&P Dow Jones Indices: LifeStance Health Group Set to Join S&P SmallCap 600 | 297 | PR Newswire | NEW YORK, April 27, 2026 /PRNewswire/ -- LifeStance Health Group Inc. (NASD: LFST) will replace Golden Entertainment Inc (NASD: GDEN) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| 06.03. | Barclays raises Lifestance Health stock price target on growth outlook | 12 | Investing.com | ||
| 02.03. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.02. | 6 Analysts Assess LifeStance Health Gr: What You Need To Know | 1 | Benzinga.com | ||
| 26.02. | KeyBanc raises Lifestance Health stock price target on productivity | 1 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 36,710 | -0,60 % | Ihre wichtigsten Termine: Allstate, Hensoldt, Atos, Richemont, Fresenius und Dürr stehen heute im Fokus! | © Foto: Britta Pedersen/zb/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,240 | +0,40 % | Dividendenbekanntmachungen (22.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,6712 EUR ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0645 EUR ADVANCED ENERGY INDUSTRIES... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,880 | -0,57 % | BARCLAYS stuft Siemens Healthineers auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Siemens Healthineers nach einer hauseigenen Management-Konferenz mit einem Kursziel von 50 Euro auf "Overweight"... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,460 | +0,84 % | EQS-Adhoc: Carl Zeiss Meditec AG: Neubesetzung des Vorstandsvorsitzes der Carl Zeiss Meditec AG | EQS-Ad-hoc: Carl Zeiss Meditec AG / Schlagwort(e): Personalentscheidungen / Vorstand
Neubesetzung des Vorstandsvorsitzes der Carl Zeiss Meditec AG
22.05.2026 / 12:37 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| TELADOC HEALTH | 6,474 | +14,30 % | Teladoc Health inks partnership with Walmart to expand virtual care services | ||
| ROKU | 112,60 | -0,79 % | The secret to Roku's success: not being cool | ||
| DEXCOM | 61,80 | +2,32 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 22.05.2026 | The following instruments on XETRA do have their last trading day on 22.05.2026.Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 22.05.2026..ISIN Name US09062X1037 Biogen Inc.US2521311074 DexCom... ► Artikel lesen | |
| INMODE | 11,960 | +0,67 % | InMode LTD: InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer | YOKNEAM, Israel, May 20, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), a leading global provider of innovative medical technologies... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| PETMED EXPRESS | 1,900 | +1,12 % | PETMED EXPRESS INC - 8-K, Current Report | ||
| TANDEM DIABETES | 14,000 | +9,38 % | TANDEM DIABETES CARE INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| ORGANON | 11,440 | -0,52 % | Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia | SEOUL, South Korea, May 21, 2026 (GLOBE NEWSWIRE) -- Hanmi Pharmaceutical announced that it has signed a supply agreement with global healthcare company Organon to export three combination medicines... ► Artikel lesen | |
| INSULET | 123,05 | -1,95 % | William Blair Initiates on Insulet (PODD) With Outperform and Says the Valuation Gap Is Hard to Justify | ||
| MOLINA HEALTHCARE | 152,60 | -0,23 % | MOLINA HEALTHCARE, INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
| QUIDELORTHO | 11,495 | +8,44 % | QuidelOrtho Corporation: QuidelOrtho Reports First Quarter 2026 Financial Results | ? LEX Diagnostics Acquisition Expected to Accelerate Growth in Point-of-Care Molecular Diagnostics ?? Key Product Launches in U.S. and International Markets Expected... ► Artikel lesen |